Skip to main content
    D

    DaVita HealthCare Partners Inc (DVA)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $172.97
    -1.25 (-0.72%)

    Market Cap: $10.96B

    Last updated: Nov 17, 2026 at 4:23 PM ET

    DaVita HealthCare Partners Inc (DVA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    DaVita HealthCare Partners (DVA) has a market cap of $10.96B and an enterprise value of $21.23B. Its share count is down 11.43% from a year earlier. Its net debt of $10.27B equals 93.75% of its market cap.

    Total Valuation

    Enterprise value is 93.75% above the market cap, as debt exceeds cash.

    Market Cap$10.96B
    Enterprise Value$21.23B
    Latest price (Nov 17, 2026)$172.97

    Key Dates

    The next earnings report is expected on Feb 1, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 1, 2027 (expected)
    Last Earnings DateOct 29, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 1.46% in the quarter ended Sep 30, 2026 and shrank 12.68% a year over 2 years.

    Shares Outstanding63.84M
    Shares Change (YoY)-11.43%
    Shares Change (QoQ)-1.46%
    Share Count Growth (2Y CAGR)-12.68%

    Valuation Ratios

    The price to sales ratio is 0.8x. Its year-end P/E ranged from 10.5x to 21.0x from 2016 to 2025.

    P/E Ratio12.3x
    Forward P/E11.7x
    P/S Ratio0.8x
    Forward P/S0.8x
    P/FCF Ratio8.5x
    P/OCF Ratio5.9x
    PEG Ratio0.5

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 7.6x EBITDA and 16.5x free cash flow.

    EV / Earnings17.4x
    EV / Sales1.5x
    EV / EBITDA7.6x
    EV / EBIT10.0x
    EV / FCF16.5x

    Price Statistics

    The stock is up 42.30% over 52 weeks and trades 5.13% below its 50-day average.

    Beta (1Y)-0.06
    52-Week Change+42.30%
    1-Month Change-7.50%
    3-Month Change-2.43%
    6-Month Change-11.12%
    5-Year Change+81.62%
    10-Year Change+219.86%
    Total Return (1Y)+42.30%
    Total Return (3Y CAGR)+21.61%
    Total Return (5Y CAGR)+11.22%
    Return vs SPY (1Y)+36.84%
    Max Drawdown (1Y)-28.22%
    Max Drawdown (3Y)-41.43%
    Sharpe Ratio (1Y)0.87
    Correlation with SPY (1Y)-0.02
    50-Day Average$182.32
    200-Day Average$181.54
    52-Week Range$101.00 to $247.49
    RSI (14 Days)40.8
    Average Volume (20 Days)846.16K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.41x current liabilities.

    Current Ratio1.41x
    Quick Ratio1.36x
    Debt / EBITDA3.82x
    Debt / FCF8.32x
    Interest Coverage3.51x

    Returns and Efficiency

    Return on invested capital is 16.40% over the last 12 months, against a 5-year average of 14.50%.

    Return on Assets (ROA)6.84%
    Return on Invested Capital (ROIC)16.40%
    Return on Capital Employed (ROCE)14.22%
    ROA (5Y Average)6.15%
    ROIC (5Y Average)14.50%
    Asset Turnover0.80x
    Inventory Turnover61.31x
    Receivables Turnover4.64x
    Cash Conversion Cycle58 days

    Taxes

    Income tax took 21.35% of pretax income over the last 12 months.

    Income Tax (TTM)$324.03M
    Effective Tax Rate21.35%

    Scores

    DVA has an Altman Z-Score of 1.69, in the distress zone below 1.81, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Altman Z-Score1.69
    Altman Z ZoneDistress
    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $14.17B over the last 12 months is up 6.38% from the 12 months before.

    Revenue$14.17B
    Revenue Growth (YoY)+6.38%
    Gross Profit$4.57B
    Operating Income$2.12B
    Pretax Income$1.52B
    Net Income$1.22B
    EBITDA$2.82B
    EBIT$2.12B
    Reported EPS (TTM)$14.11

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$495.63M
    Total Debt$10.77B
    Net Debt$10.27B
    Net Debt Per Share$160.94
    Working Capital$1.19B
    Shareholder Equity-$591.09M
    Tangible Book Value-$8.36B
    Total Assets$17.82B
    Total Liabilities$16.69B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $576.75M of capital spending, operating cash flow left $1.29B of free cash flow.

    Operating Cash Flow$1.87B
    Capital Expenditures$576.75M
    Free Cash Flow$1.29B
    FCF Per Share$20.16
    Depreciation and Amortization$697.53M
    Share Repurchases$725.34M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 14.97%, against a 5-year average of 14.30%.

    Gross Margin32.28%
    Operating Margin14.97%
    Pretax Margin10.71%
    Net Margin8.60%
    EBITDA Margin19.90%
    EBIT Margin14.98%
    FCF Margin9.13%
    Gross Margin (5Y Average)31.46%
    Operating Margin (5Y Average)14.30%
    Net Margin (5Y Average)8.54%

    Growth

    Revenue grew 5.53% a year over 3 years, and EPS 22.21% a year.

    Revenue Growth (3Y CAGR)+5.53%
    Revenue Growth (5Y CAGR)+3.39%
    EPS Growth (3Y CAGR)+22.21%
    EPS Growth (5Y CAGR)+8.42%
    FCF Growth (3Y CAGR)+10.89%
    FCF Growth (5Y CAGR)+0.09%
    Operating Income Growth (3Y CAGR)+15.13%

    Revenue and profit by year

    Dividends and Yields

    DVA does not pay a dividend. Its free cash flow yield is 11.72%.

    Earnings Yield8.13%
    FCF Yield11.72%
    Buyback Yield6.28%
    Shareholder Yield10.05%

    Stock Splits

    The last split was a 2-for-1 forward split on Sep 9, 2013.

    Last Split DateSep 9, 2013
    Split TypeForward split
    Split Ratio2:1

    Peer Position

    Against 12 similar companies, DVA has the 11th highest P/E and the 11th highest P/S.

    P/E Ratio12.3x vs 21.7x median
    P/S Ratio0.8x vs 1.2x median
    ROIC16.40% vs 11.82% median
    Revenue Growth (Trailing 4 Quarters, YoY)+6.38% vs +8.68% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 3.98% and EPS growth at 24.66% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+3.98%
    EPS Growth Forecast (2Y CAGR)+24.66%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About DVA

    What is DVA's market cap?

    DaVita HealthCare Partners has a market cap of $10.96B. Its enterprise value, which adds debt and subtracts cash, is $21.23B.

    What is DVA's P/E ratio?

    DaVita HealthCare Partners has a trailing P/E ratio of 12.3x and a forward P/E of 11.7x.

    How many shares of DVA are outstanding?

    DaVita HealthCare Partners has 63.84M shares outstanding. The count is down 11.43% from a year earlier.

    Does DVA pay a dividend?

    No. DaVita HealthCare Partners does not pay a dividend.

    How much debt does DVA have?

    DaVita HealthCare Partners has $10.77B of total debt and $495.63M of cash and equivalents, a net debt position of $10.27B.